Laobaixing Pharmacy Cash Flow Conversion Efficiency

Latest as of September 2025: 0.075x

Laobaixing Pharmacy cash flow conversion efficiency. Based on the latest financial reports, Laobaixing Pharmacy (603883) has a cash flow conversion efficiency ratio of 0.075x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥538.25 Million ≈ $78.76 Million USD) by net assets (CN¥7.20 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Laobaixing Pharmacy (2011–2025)

Cash flow conversion efficiency of Laobaixing Pharmacy from 2011 to 2025. This chart illustrates how Laobaixing Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Laobaixing Pharmacy (603883) share price today for real-time trading data and today's change.

Laobaixing Pharmacy Cash Flow Conversion Ratio Explained

Laobaixing Pharmacy cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Laobaixing Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laobaixing Pharmacy ranked by their cash flow conversion efficiency. Also see Laobaixing Pharmacy stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
HAMB.H.U.L. UNSP.ADR/1/2 F:HHFB	N/A
Etablissements Maurel et Prom SA PA:MAU	0.075x
TriCo Bancshares NASDAQ:TCBK	0.019x
SJM HOLDINGS UNSP.ADR/4 F:3MG1	N/A
Playa Hotels & Resorts BV NASDAQ:PLYA	0.147x
National Bank Holdings Corporation NYSE:NBHC	0.081x
Mach Natural Resources LP NYSE:MNR	0.147x
Veritex Holdings Inc NASDAQ:VBTX	0.017x

Annual Cash Flow Conversion Efficiency for Laobaixing Pharmacy (2011–2025)

The table below shows the annual cash flow conversion efficiency of Laobaixing Pharmacy from 2011 to 2025. Review Laobaixing Pharmacy (603883) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.00 Billion ≈ $1.02 Billion	CN¥3.14 Billion ≈ $459.87 Million	0.449x	+58.91%
2024-12-31	CN¥7.17 Billion ≈ $1.05 Billion	CN¥2.03 Billion ≈ $296.53 Million	0.283x	-24.52%
2023-12-31	CN¥7.29 Billion ≈ $1.07 Billion	CN¥2.73 Billion ≈ $399.46 Million	0.375x	+14.86%
2022-12-31	CN¥7.10 Billion ≈ $1.04 Billion	CN¥2.31 Billion ≈ $338.66 Million	0.326x	-32.20%
2021-12-31	CN¥4.78 Billion ≈ $699.30 Million	CN¥2.30 Billion ≈ $336.31 Million	0.481x	+59.66%
2020-12-31	CN¥4.81 Billion ≈ $703.18 Million	CN¥1.45 Billion ≈ $211.81 Million	0.301x	+13.04%
2019-12-31	CN¥3.87 Billion ≈ $567.00 Million	CN¥1.03 Billion ≈ $151.09 Million	0.266x	-1.66%
2018-12-31	CN¥3.37 Billion ≈ $493.04 Million	CN¥913.03 Million ≈ $133.60 Million	0.271x	+70.76%
2017-12-31	CN¥3.10 Billion ≈ $453.79 Million	CN¥492.13 Million ≈ $72.01 Million	0.159x	-1.45%
2016-12-31	CN¥1.95 Billion ≈ $284.66 Million	CN¥313.26 Million ≈ $45.84 Million	0.161x	+43.53%
2015-12-31	CN¥2.29 Billion ≈ $335.39 Million	CN¥257.15 Million ≈ $37.63 Million	0.112x	-50.72%
2014-12-31	CN¥1.09 Billion ≈ $158.86 Million	CN¥247.14 Million ≈ $36.17 Million	0.228x	+52.82%
2013-12-31	CN¥916.46 Million ≈ $134.11 Million	CN¥136.52 Million ≈ $19.98 Million	0.149x	-26.69%
2012-12-31	CN¥732.59 Million ≈ $107.20 Million	CN¥148.85 Million ≈ $21.78 Million	0.203x	-6.94%
2011-12-31	CN¥607.41 Million ≈ $88.88 Million	CN¥132.62 Million ≈ $19.41 Million	0.218x	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.66 Billion

CN¥11.34 Billion CNY

Market Cap Rank

#6614 Global

#1326 in China

Share Price

CN¥14.94

Change (1 day)

+1.36%

52-Week Range

CN¥10.96 - CN¥17.57

All Time High

CN¥331.82